A set of 6 separate vials. Each set contains 250 mg each of :

• Bisindolylmaleimide I, HCl (Cat. No. 203291)
• Bisindolylmaleimide II (Cat. No. 203292)
• Bisindolylmaleimide III, HCl (Cat. No. 203294)
• Bisindolylmaleimide IV (Cat. No. 203297)
• Bisindolylmaleimide V (Cat. No. 203303)
• RIM-1 (Cat. No. 557325)

Provided as a 5 vial set. Each set contains:

• 5 mg ALLN (Cat. No. 208719)
• 25 mg Calpain Inhibitor III (Cat. No. 208722)
• 5 mg of Calpeptin (Cat. No. 03-34-0051)
• 1 mg of EST (Cat. No. 330005)
• 5 mg of PD 150606 (Cat. No. 513022).

The set of 3 separate vials. Each set contains 1 mg of:

• Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155)
• Caspase-1 Inhibitor I, Ac-YVAD-CHO (Cat. No. 400010)
• Caspase Inhibitor I, Z-VAD-FMK (Cat. No. 627610).

The set of 8 separate vials. Each set contains 250 mg of:

• Caspase-1 Inhibitor VI, Z-YVAD-FMK (Cat. No. 218746)
• Caspase-2 Inhibitor I, Z-VDVAD-FMK (Cat. No. 218744)
• Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155)
• Caspase-5 Inhibitor I, ZWEHD- FMK (Cat. No. 218753)
• Caspase-6 Inhibitor I, Z-VEIDFMK (Cat. No. 218757)
• Caspase-8 Inhibitor II, Z-IETD-FMK (Cat. No. 218759)
• Caspase-9 Inhibitor I, Z-LEHD-FMK (Cat. No. 218761)
• Caspase Inhibitor III, Boc-D-FMK (Cat. No. 218745).

A set of 8 separate vials. Each set contains a ready-to-use DMSO solution of irreversible inhibitors of various members of the caspase-family proteases. Contains 25 ml (2 mM) each of:

• Caspase-1 Inhibitor VI, Z-YVAD-FMK (Cat. No. 218746)
• Caspase-2 Inhibitor I, Z-VDVAD-FMK (Cat. No. 218744)
• Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155)
• Caspase-5 Inhibitor I, Z-WEHD-FMK (Cat. No. 218753)
• Caspase-6 Inhibitor I, Z-VEID-FMK (Cat. No. 218757)
• Caspase-8 Inhibitor II, Z-IETD-FMK (Cat. No. 218759)
• Caspase-9 Inhibitor I, Z-LEHD-FMK (Cat. No. 218761)
• Caspase Inhibitor I, Z-VAD-FMK (Cat. No. 627610).

A set of 6 separate vials. Each set contains a ready-to-use solution of reagents for caspase inhibition studies and an apoptosis inducer. Contains 25 ml of a 10 mM solution in DMSO of:

• Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155)
• Caspase-8 Inhibitor II, Z-IETD-FMK (Cat. No. 218759)
• Caspase-9 Inhibitor I, Z-LEHD-FMK (Cat. No 218761)
• General caspase inhibitor, Z-VAD-FMK (Cat. No. 627610)
• The negative control Z-FA-FMK (Cat. No. 342000)
• An aqueous solution (100 ml, 10.5 mM) of an apoptosis inducer, Doxorubicin, Hydrochloride (Cat. No. 324380).

Provided as a 3 vial set. Each set contains:

• 5 mg of Olomoucine (Cat. No. 495620)
• 1 mg of Iso-Olomoucine (Cat. No. 495622)
• 1 mg of Roscovitine (Cat. No. 557360)

Provided as a 4 vial set. Each set contains:

• 100 mg of Meloxicam (Cat. No. 444800)
• 5 mg of NS-398 (Cat. No. 349254)
• 5 mg of SC-560 (Cat. No. 565610)
• 5 mg of Sulindac Sulfide (Cat. No. 574102).

A set of 5 vials. Each set contains:

• 1 mg of FPT Inhibitor III (Cat. No. 344154)
• 1 mg of ZM 336372 (Cat. No. 692000)
• 5 mg of PD 98059 (Cat. No. 513000)
• 1 mg of SB 203580 (Cat. No. 559389)

A set of 4 vials. Each set contains:

• 5 mg of the MEK inhibitor PD 98059 (Cat. No. 513000)
• 1 mg of the MAP kinase inhibitors SB 202190 (Cat. No. 559388)
• 1 mg of SB 203580 (Cat. No. 559389)
• 1 mg of the negative control, SB 202474 (Cat. No. 559387)

A set of 4 vials. Each set contains:

• 5 mg of PD 98059 (Cat. No. 513000)
• 1 mg of SB 203580 (Cat. No. 559389)
• 1 mg of U0126 (Cat. No. 662005)
• 1 mg of the negative control, SB 202474 (Cat. No. 559387)

A set of 3 vials. Each set contains:

• 5 mg of PD 98059 (Cat. No. 513000)
• 1 mg of U0126 (Cat. No. 662005)
• 1 mg of the negative control U0124 (Cat. No. 662006)

• 5 mg of MMP-2/MMP-9 Inhibitor I (Cat. No. 444241)
• 5 mg of MMP-3 Inhibitor II (Cat. No. 444225)
• 1 mg of GM 6001(Cat. No. 364205)
• 1 mg of GM 6001, Negative Control (Cat. No. 364210)
• 1 mg of MMP-8 Inhibitor I (Cat. No. 444237)

Provided as a 5 vial set. Each set contains:

• 5 mg of 1400W (Cat. No. 100050)
• 10 mg of 1-Amino-2-hydroxyguanidine, p-Toluenesulfonate (Cat. No. 155200)
• 100 mg of S-Methylisothiourea Sulfate (Cat. No. 466220)
• 10 mg of L-NIL, Dihydrochloride (Cat. No. 482100)
• 50 mg of 1,3-PBITU, Dihydrobromide (Cat. No. 512774).

• 20 mg of L-N⁵-(1-Iminoethyl)ornithine, HCl (Cat. No. 400600)
• 10 mg of S-Methyl-L-thiocitrulline, HCl (Cat. No. 472804)
• 25 mg of N^G-Monomethyl-L-arginine, Monoacetate Salt (Cat. No. 475886)
• 100 mg of N^G-Nitro-L-arginine Methyl Ester, HCl (Cat. No. 483125)
• 100 mg of N^G-Nitro-D-arginine Methyl Ester, HCl, 100 mg of 7-Nitroindazole (Cat. No. 483400)
• 10 mg of L-Thiocitrulline, HCl (Cat. No. 589411)

Provided as a 5 vial set. Each set contains

• 100 mg of 3-Aminobenzamide (Cat. No. 165350)
• 5 mg of 5-Iodo-6-amino- 1,2-benzopyrone (Cat. No. 407850)
• 5 mg of 1,5-Isoquinolinediol (Cat. No. 419800)
• 5 mg of NU 1025 (Cat. No. 493800)
• 1 mg of DPQ (Cat. No. 300270)

Provided as a set of 4 vials. Each set contains:

• 10 mg of 8-Methoxymethyl-3- isobutyl-1-methylxanthine (Cat. No. 454202), a Ca²⁺/CaM-dependent PDE (PDE I) inhibitor
• 1 mg of 4-{[3,4 -(Methylenedioxy)benzyl]amino}-6-methoxyquinazoline (Cat. No. 475250), a cGMP-specific PDE (PDE V) inhibitor
• 5 mg of Rolipram (Cat. No. 557330), a cAMP-specific PDE (PDE IV) inhibitor
• 10 mg of Trequinsin, Hydrochloride (Cat. No. 382425), a cGMP-inhibited PDE (PDE III) inhibitor.

Provided as a set of 3 vials. Each set contains:

• 5 g of Sodium Orthovanadate (Cat. No. 567540)
• 10 mg of bpV(phen) (Cat. No. 203695)
• 10 mg of mpV(pic) (Cat. No. 475950)

A set of three vials. Each set contains:

• 1 mg of Proteasome Inhibitor I (Cat. No. 539160)
• 200 mg of Lactacystin (Cat. No. 426100)
• 1 mg of MG-132 (Cat. No. 474790).

A set of three vials. Each set contains:

• 5 mg of ALLN (Cat. No. 208719)
• 100 mg of Epoxomicin (Cat. No. 324800)
• 100 mg of clasto-Lactacystin b-Lactone (Cat. No. 426102).

A set of 6 vials. Each set contains:

• 250 mg of Bisindolylmaleimide I (Cat. No. 203290)
• 50 mg of Calphostin C, Cladosporium cladosporioides (Cat. No. 208725)
• 5 mg of Chelerythrine Chloride (Cat. No. 220285)
• 500 mg of Gö 6976 (Cat. No. 365250)
• 500 mg of Myristoylated Protein Kinase C Inhibitor 20-28, Cell-Permeable (Cat. No. 476480)
• 500 mg of Ro-32-0432 (Cat. No. 557525)

A set of 6 vials. Each set contains:

• 500 mg of Ro-31-8220 (Cat. No. 557520)
• 20 mg of Genistein (Cat. No. 345834)
• 1 mg of KN-93, Water-Soluble (Cat. No. 422711)
• 50 mg of KT5720 (Cat. No. 420320)
• 100 mg of Staurosporine, Streptomyces sp. (Cat. No. 569397)
• 1 mg of U0126 (Cat. No. 662005)

A set of 6 vials. Each set contains:

• 250 mg of PKC inhibitor, Bisindolylmaleimide I (Cat. No. 203290)
• 1 mg of PKA inhibitor, H-89, Dihydrochloride (Cat. No. 371963)
• 1 mg of PKG inhibitor, Protein Kinase G Inhibitor (Cat. No. 370654)
• 1 mg of MLCK inhibitor, ML-7 (Cat. No. 475880)
• 1 mg of CaM kinase II inhibitor, KN-93 (Cat. No. 422708)
• 100 mg of the broad range inhibitor, Staurosporine (Cat. No. 569397) Not available for sale in Japan.

A set of 4 vials. Each set contains:

• 20 mg of Genistein (Cat. No. 345834)
• 100 mg of Herbimycin A, Streptomyces sp. (Cat. No. 375670)
• 1 mg of PP2 (Cat. No. 529573)
• 1 mg of PP3 (Cat. No. 529574)

A set of 4 vials. Each set contains:

• 20 mg of Genistein (Cat. No. 345834)
• 1 mg of PP2 (Cat. No. 529573)
• 5 mg of AG 490 (Cat. No. 658401)
• 5 mg of AG 1296 (Cat. No. 658551)
• 5 mg of AG 1478 (Cat. No. 658552)